Cartesian Therapeutics, Inc. (RNAC) Net income 2016–2025
Cartesian Therapeutics, Inc. (RNAC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$130.3MFY2025 · since FY2016: -$36.2M → -$130.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$130.3M | -68.3% |
| FY2024 | -$77.4M | +64.8% |
| FY2023 | -$219.7M | -721.0% |
| FY2022 | $35.4M | +237.7% |
| FY2021 | -$25.7M | +62.7% |
| FY2020 | -$68.9M | -24.4% |
| FY2019 | -$55.4M | +15.3% |
| FY2018 | -$65.3M | -0.0% |
| FY2017 | -$65.3M | -80.4% |
| FY2016 | -$36.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice